GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
J3370
Injection, vancomycin hcl, 500 mg
HCPCS code
Similar Codes
ICD10CM codes
Z30.013
- Encounter for initial prescription of injectable contraceptive
T80.90XA
- Unspecified complication following infusion and therapeutic injection, initial encounter
Z29.12
- Encounter for prophylactic antivenin
Z30.42
- Encounter for surveillance of injectable contraceptive
Z16.21
- Resistance to vancomycin
T80.90
- Unspecified complication following infusion and therapeutic injection
T37.5X4
- Poisoning by antiviral drugs, undetermined
T80.90XD
- Unspecified complication following infusion and therapeutic injection, subsequent encounter
Z16.22
- Resistance to vancomycin related antibiotics
T80.810A
- Extravasation of vesicant antineoplastic chemotherapy, initial encounter
HCPCS codes
J3370
- Injection, vancomycin hcl, 500 mg
J1570
- Injection, ganciclovir sodium, 500 mg
J0690
- Injection, cefazolin sodium, 500 mg
J0290
- Injection, ampicillin sodium, 500 mg
J1335
- Injection, ertapenem sodium, 500 mg
J0875
- Injection, dalbavancin, 5 mg
J0692
- Injection, cefepime hydrochloride, 500 mg
S0073
- Injection, aztreonam, 500 mg
S0030
- Injection, metronidazole, 500 mg
J9190
- Injection, fluorouracil, 500 mg
CPT4 codes
80202
- Vancomycin
80170
- Gentamicin
83150
- Homovanillic acid (HVA)
90284
- Immune globulin (SCIg), human, for use in subcutaneous infusions, 100 mg, each
0031A
- Janssen Covid-19 Vaccine Administration
96379
- Unlisted therapeutic, prophylactic, or diagnostic intravenous or intra-arterial injection or infusio
90396
- Varicella-zoster immune globulin, human, for intramuscular use
80285
- Voriconazole
46500
- Injection of sclerosing solution, hemorrhoids
36598
- Contrast injection(s) for radiologic evaluation of existing central venous access device, including